Literature DB >> 29847819

A New Model for Adrenarche: Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 2 by Intra-Adrenal Cortisol.

Joseph A Majzoub1, Lisa Swartz Topor2.   

Abstract

We propose that the normal adrenarche-related rise in dehydroepiandrosterone (DHEA) secretion is ultimately caused by the rise in cortisol production occurring during childhood and adolescent growth, by the following mechanisms. (1) The onset of childhood growth leads to a slight fall in serum cortisol concentration due to growth-induced dilution and a decrease in the negative feedback of cortisol upon ACTH secretion. (2) In response, ACTH rises and stimulates increased cortisol synthesis and secretion in the growing body to restore the serum cortisol concentration to normal. (3) The cortisol concentration produced within and taken up by adrenocortical steroidogenic cells may rise during this time. (4) Cortisol competitively inhibits 3β-hydroxysteroid dehydrogenase type 2 (3βHSD2)-mediated conversion of 17αOH-pregnenolone to cortisol, causing a further fall in serum cortisol, a further decrease in the negative feedback of cortisol upon ACTH, a further rise in ACTH, and further stimulation of adrenal steroidogenesis. (5) The cortisol-mediated inhibition of 3βHSD2 also blocks the conversion of DHEA to androstenedione, causing a rise in adrenal DHEA and DHEA sulfate relative to androstenedione secretion. Thus, the combination of normal body growth plus inhibition of 3βHSD2 by intra-adrenal cortisol may cause normal adrenarche. Childhood obesity may hasten this process by causing a pathologic increase in body size that triggers these same processes at an earlier age, resulting in the premature onset of adrenarche.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  3βHSD2; Competitive; DHEA; End product; Obesity; Steroidogenesis

Mesh:

Substances:

Year:  2018        PMID: 29847819      PMCID: PMC6031466          DOI: 10.1159/000488777

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  52 in total

1.  Morphology of the human adrenarche.

Authors:  G Dhom
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1973

Review 2.  Minireview: regulation of steroidogenesis by electron transfer.

Authors:  Walter L Miller
Journal:  Endocrinology       Date:  2005-03-17       Impact factor: 4.736

3.  Regulation of human 3β-hydroxysteroid dehydrogenase type 2 by adrenal corticosteroids and product-feedback by androstenedione in human adrenarche.

Authors:  James L Thomas; Maheshinie Rajapaksha; Vance L Mack; Geneva A DeMars; Joseph A Majzoub; Himangshu S Bose
Journal:  J Pharmacol Exp Ther       Date:  2014-10-29       Impact factor: 4.030

Review 4.  Adrenarche.

Authors:  L N Parker
Journal:  Endocrinol Metab Clin North Am       Date:  1991-03       Impact factor: 4.741

5.  Clinical characteristics of 104 children referred for evaluation of precocious puberty.

Authors:  Paul Kaplowitz
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

6.  Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index.

Authors:  Johannes D Veldhuis; Ferdinand Roelfsema; Ali Iranmanesh; Bernard J Carroll; Daniel M Keenan; Steven M Pincus
Journal:  J Clin Endocrinol Metab       Date:  2009-09-15       Impact factor: 5.958

7.  Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.

Authors:  E Rhéaume; Y Lachance; H F Zhao; N Breton; M Dumont; Y de Launoit; C Trudel; V Luu-The; J Simard; F Labrie
Journal:  Mol Endocrinol       Date:  1991-08

8.  Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.

Authors:  Chantal Lutfallah; Weihua Wang; J Ian Mason; Ying Tai Chang; Anzar Haider; Barry Rich; Mariano Castro-Magana; Kenneth C Copeland; Raphael David; Songya Pang
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

9.  Inactivating PAPSS2 mutations in a patient with premature pubarche.

Authors:  Cees Noordam; Vivek Dhir; Joanne C McNelis; Florian Schlereth; Neil A Hanley; Nils Krone; Jan A Smeitink; Roel Smeets; Fred C G J Sweep; Hedi L Claahsen-van der Grinten; Wiebke Arlt
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

10.  Intraadrenal steroid concentrations in man: zonal differences and developmental changes.

Authors:  Z Dickerman; D R Grant; C Faiman; J S Winter
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

View more
  2 in total

Review 1.  Normal and Premature Adrenarche.

Authors:  Robert L Rosenfield
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

Review 2.  A lex naturalis delineates components of a human-specific, adrenal androgen-dependent, p53-mediated 'kill switch' tumor suppression mechanism.

Authors:  Jonathan Wesley Nyce
Journal:  Endocr Relat Cancer       Date:  2020-02       Impact factor: 5.678

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.